Fidaxomicin - a new kid in the block to treat C.Diff.
Fidaxomicin is a narrow spectrum macrocyclic non-systemic antibiotic drugs. It is bactericidal, and causes selective eradication of pathogenic Clostridium difficile with minimal disruption of the other bacteria that make up the normal, healthy intestinal flora. As evident, the maintenance of normal physiological conditions in the colon is the best defense against the probability of Clostridium difficile infection recurrence.
Dose is 200 mg tablet every 12 hours for the duration of 10 days.